Retronectin GMP grade reagent

Ended Purchase Order Awarded

Contract number
75N90024P00105
Awardee
Awarding agency
Obligated
$46,008

Award facts

Contract value 100% obligated
$46,008.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
San Jose, CA 95131, USA

Award details come from SAM.gov/FPDS.

About this award

Takara Bio USA, Inc. was awarded a firm fixed-price purchase order valued at forty-six thousand eight dollars by the Department of Health and Human Services' National Institutes of Health Clinical Center. Under this contract, Takara Bio will provide Retronectin GMP Grade Reagent to the agency. The place of performance is in San Jose, California and the period of performance concludes on February 9, 2024. No set-aside designation was applied to this award to procure the requested biomedical products in support of the NIH Clinical Center's research and treatment initiatives.

Quick answers

Who was awarded contract 75N90024P00105?

75N90024P00105 was awarded to Takara Bio Usa, Inc. by NIH Clinical Center (National Institutes of Health) on January 10, 2024.

How much is contract 75N90024P00105 worth?

The government has obligated $46,008 on 75N90024P00105.

Was contract 75N90024P00105 competed?

The extent of competition for 75N90024P00105 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award